Sanofi SA (SNY)
47.71
+0.55
(+1.17%)
USD |
NASDAQ |
Apr 23, 16:00
47.71
0.00 (0.00%)
After-Hours: 20:00
Sanofi 1 Year Total Returns (Daily): -13.69% for April 22, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| April 22, 2024 | -13.69% |
| April 19, 2024 | -13.78% |
| April 18, 2024 | -14.67% |
| April 17, 2024 | -14.41% |
| April 16, 2024 | -15.36% |
| April 15, 2024 | -14.55% |
| April 12, 2024 | -14.59% |
| April 11, 2024 | -12.43% |
| April 10, 2024 | -11.07% |
| April 09, 2024 | -11.82% |
| April 08, 2024 | -12.52% |
| April 05, 2024 | -10.60% |
| April 04, 2024 | -8.50% |
| April 03, 2024 | -8.15% |
| April 02, 2024 | -9.05% |
| April 01, 2024 | -7.92% |
| March 28, 2024 | -6.94% |
| March 27, 2024 | -3.41% |
| March 26, 2024 | -1.87% |
| March 25, 2024 | -2.49% |
| March 22, 2024 | 2.24% |
| March 21, 2024 | 1.99% |
| March 20, 2024 | 4.26% |
| March 19, 2024 | 3.20% |
| March 18, 2024 | 3.96% |
| Date | Value |
|---|---|
| March 15, 2024 | 5.34% |
| March 14, 2024 | 4.26% |
| March 13, 2024 | 6.44% |
| March 12, 2024 | 6.36% |
| March 11, 2024 | 6.11% |
| March 08, 2024 | 6.01% |
| March 07, 2024 | 4.86% |
| March 06, 2024 | 3.66% |
| March 05, 2024 | 3.20% |
| March 04, 2024 | 2.44% |
| March 01, 2024 | 4.36% |
| February 29, 2024 | 5.98% |
| February 28, 2024 | 6.31% |
| February 27, 2024 | 4.55% |
| February 26, 2024 | 4.85% |
| February 23, 2024 | 4.75% |
| February 22, 2024 | 3.29% |
| February 21, 2024 | 4.46% |
| February 20, 2024 | 1.98% |
| February 16, 2024 | 2.33% |
| February 15, 2024 | 1.88% |
| February 14, 2024 | -0.16% |
| February 13, 2024 | 0.15% |
| February 12, 2024 | 1.15% |
| February 09, 2024 | 0.36% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-21.11%
Minimum
Sep 06 2022
50.96%
Maximum
Sep 26 2023
8.28%
Average
7.26%
Median
1 Year Total Returns (Daily) Benchmarks
| AstraZeneca PLC | -5.20% |
| GSK PLC | 15.07% |
| Novo Nordisk A/S | 46.86% |
| Regeneron Pharmaceuticals Inc | 12.42% |
| Inhibrx Inc | 60.70% |